Literature DB >> 22205573

Brain serum amyloid P levels are reduced in individuals that lack dementia while having Alzheimer's disease neuropathology.

Jeffrey R Crawford1, Nicole L Bjorklund, Giulio Taglialatela, Richard H Gomer.   

Abstract

The neuropathological signs of Alzheimer's disease (AD) include beta amyloid plaques and neurofibrillary tangles. There is a significant population of individuals that have these key hallmarks but show no signs of cognitive impairment, termed non-demented with AD neuropathology (NDAN). The protective mechanism allowing these individuals to escape dementia is unknown. Serum amyloid P (SAP) is a serum protein associated with wound repair that is elevated in the brains of Alzheimer's patients and binds to amyloid plaques. Using immunoblotting and immunohistochemistry, we evaluated SAP levels in postmortem samples of hippocampus and frontal cortex in age-matched controls, AD, and NDAN individuals. AD individuals had significantly increased SAP levels compared to normal controls, while NDAN samples had no significant difference in SAP levels compared to normal controls. Our results suggest that low levels of SAP in plaques marks the brains of individuals that escape dementia despite the presence of beta amyloid plaques and tangles.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22205573      PMCID: PMC3299926          DOI: 10.1007/s11064-011-0674-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  38 in total

1.  TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P.

Authors:  Lynne A Murray; Qingsheng Chen; Michael S Kramer; David P Hesson; Rochelle L Argentieri; Xueyang Peng; Mridu Gulati; Robert J Homer; Thomas Russell; Nico van Rooijen; Jack A Elias; Cory M Hogaboam; Erica L Herzog
Journal:  Int J Biochem Cell Biol       Date:  2010-10-29       Impact factor: 5.085

Review 2.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

3.  Serum amyloid P attenuates M2 macrophage activation and protects against fungal spore-induced allergic airway disease.

Authors:  Ana Paula Moreira; Karen A Cavassani; Rikki Hullinger; Rogério S Rosada; Daniel J Fong; Lynne Murray; Dave P Hesson; Cory M Hogaboam
Journal:  J Allergy Clin Immunol       Date:  2010-07-31       Impact factor: 10.793

4.  Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.

Authors:  F Coria; E Castaño; F Prelli; M Larrondo-Lillo; S van Duinen; M L Shelanski; B Frangione
Journal:  Lab Invest       Date:  1988-04       Impact factor: 5.662

5.  Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.

Authors:  M B Pepys; J Herbert; W L Hutchinson; G A Tennent; H J Lachmann; J R Gallimore; L B Lovat; T Bartfai; A Alanine; C Hertel; T Hoffmann; R Jakob-Roetne; R D Norcross; J A Kemp; K Yamamura; M Suzuki; G W Taylor; S Murray; D Thompson; A Purvis; S Kolstoe; S P Wood; P N Hawkins
Journal:  Nature       Date:  2002-05-16       Impact factor: 49.962

6.  The structures of crystalline complexes of human serum amyloid P component with its carbohydrate ligand, the cyclic pyruvate acetal of galactose.

Authors:  D Thompson; M B Pepys; I Tickle; S Wood
Journal:  J Mol Biol       Date:  2002-07-26       Impact factor: 5.469

7.  Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital.

Authors:  C Bouras; P R Hof; P Giannakopoulos; J P Michel; J H Morrison
Journal:  Cereb Cortex       Date:  1994 Mar-Apr       Impact factor: 5.357

Review 8.  Pattern recognition by pentraxins.

Authors:  Alok Agrawal; Prem Prakash Singh; Barbara Bottazzi; Cecilia Garlanda; Alberto Mantovani
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

9.  Frequent amyloid deposition without significant cognitive impairment among the elderly.

Authors:  Howard Jay Aizenstein; Robert D Nebes; Judith A Saxton; Julie C Price; Chester A Mathis; Nicholas D Tsopelas; Scott K Ziolko; Jeffrey A James; Beth E Snitz; Patricia R Houck; Wenzhu Bi; Ann D Cohen; Brian J Lopresti; Steven T DeKosky; Edythe M Halligan; William E Klunk
Journal:  Arch Neurol       Date:  2008-11

Review 10.  Amyloidosis.

Authors:  Mark B Pepys
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

View more
  10 in total

1.  Interacting partners of macrophage-secreted cathepsin B contribute to HIV-induced neuronal apoptosis.

Authors:  Yisel M Cantres-Rosario; Natalia Hernandez; Karla Negron; Juliana Perez-Laspiur; John Leszyk; Scott A Shaffer; Loyda M Meléndez
Journal:  AIDS       Date:  2015-10-23       Impact factor: 4.177

2.  Inhibition of Cathepsin B and SAPC Secreted by HIV-Infected Macrophages Reverses Common and Unique Apoptosis Pathways.

Authors:  Camille N Zenón-Meléndez; Kelvin Carrasquillo Carrión; Yadira Cantres Rosario; Abiel Roche Lima; Loyda M Meléndez
Journal:  J Proteome Res       Date:  2022-01-07       Impact factor: 5.370

3.  Efflux transport of serum amyloid P component at the blood-brain barrier.

Authors:  Szilvia Veszelka; Judit Laszy; Tamás Pázmány; László Németh; Izabella Obál; László Fábián; Gábor Szabó; Csongor S Abrahám; Mária A Deli; Zoltán Urbányi
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-11-21

4.  Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD).

Authors:  Paul L Wood; Victoria A Locke; Patrick Herling; Angelina Passaro; Giovanni B Vigna; Stefano Volpato; Giuseppe Valacchi; Carlo Cervellati; Giovanni Zuliani
Journal:  BBA Clin       Date:  2015-11-14

5.  HIV Infection Induces Extracellular Cathepsin B Uptake and Damage to Neurons.

Authors:  Yisel M Cantres-Rosario; Sarah C Ortiz-Rodríguez; Aemil G Santos-Figueroa; Marines Plaud; Karla Negron; Bianca Cotto; Dianne Langford; Loyda M Melendez
Journal:  Sci Rep       Date:  2019-05-29       Impact factor: 4.379

6.  Dementia in the older population is associated with neocortex content of serum amyloid P component.

Authors:  Stephan Ellmerich; Graham W Taylor; Connor D Richardson; Thais Minett; Amand Floriaan Schmidt; Carol Brayne; Fiona E Matthews; Paul G Ince; Stephen B Wharton; Mark B Pepys
Journal:  Brain Commun       Date:  2021-10-09

7.  Inflammatory Biomarkers Predict Domain-Specific Cognitive Decline in Older Adults.

Authors:  Gloria C Chi; Annette L Fitzpatrick; Monisha Sharma; Nancy S Jenny; Oscar L Lopez; Steven T DeKosky
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-06-01       Impact factor: 6.053

Review 8.  Acetyl-CoA the key factor for survival or death of cholinergic neurons in course of neurodegenerative diseases.

Authors:  Andrzej Szutowicz; Hanna Bielarczyk; Agnieszka Jankowska-Kulawy; Tadeusz Pawełczyk; Anna Ronowska
Journal:  Neurochem Res       Date:  2013-05-16       Impact factor: 3.996

9.  Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo.

Authors:  Raya Al-Shawi; Glenys A Tennent; David J Millar; Angela Richard-Londt; Sebastian Brandner; David J Werring; J Paul Simons; Mark B Pepys
Journal:  Open Biol       Date:  2016-02       Impact factor: 6.411

Review 10.  The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs.

Authors:  Mark B Pepys
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.